Chen Peijie, Pan Xiang, Zhao Liwen, Jin Lu, Lin Canbin, Quan Jing, He Tao, Zhou Liang, Wu Xueling, Wang Yong, Ni Liangchao, Yang Shangqi, Lai Yongqing
Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Department of Urology, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China.
Exp Ther Med. 2018 Feb;15(2):1686-1693. doi: 10.3892/etm.2017.5581. Epub 2017 Nov 28.
Renal cell carcinoma (RCC) is a common tumor of the urinary system. Previously, miR-191-5p has been reported to be associated with various types of cancer; however, its specific functions in RCC have not been investigated to date. In the present study, the expression of miR-191-5p in the 786-O and ACHN cell lines was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The results of RT-qPCR revealed that miR-191-5p was significantly downregulated in the two cell lines compared with the 293T cell line. miR-191-5p was also significantly downregulated in RCC tissue compared with paired normal tissue. In addition, the effects of miR-191-5p on cell proliferation, migration, invasion and apoptosis were examined by CCK-8, MTT, wound scratch, Transwell and flow cytometry assays. Downregulation of miR-191-5p was observed to promote cell proliferation, migration and invasion, as well as to repress the cell apoptosis of 786-O and ACHN cells. Therefore, the current study suggests that miR-191-5p functions as a tumor suppressor in RCC. Further studies are required to uncover the underlying signaling pathway of miR-191-5p and its potential role as a biomarker for early detection and prognosis prediction, and as a therapeutic target of RCC.
肾细胞癌(RCC)是泌尿系统的常见肿瘤。此前,已有报道称miR-191-5p与多种类型的癌症相关;然而,其在RCC中的具体功能迄今尚未得到研究。在本研究中,通过逆转录-定量聚合酶链反应(RT-qPCR)检测了miR-191-5p在786-O和ACHN细胞系中的表达。RT-qPCR结果显示,与293T细胞系相比,miR-191-5p在这两种细胞系中显著下调。与配对的正常组织相比,miR-191-5p在RCC组织中也显著下调。此外,通过CCK-8、MTT、划痕试验、Transwell和流式细胞术检测了miR-191-5p对细胞增殖、迁移、侵袭和凋亡的影响。观察到miR-191-5p的下调促进了786-O和ACHN细胞的增殖、迁移和侵袭,并抑制了细胞凋亡。因此,当前研究表明miR-191-5p在RCC中发挥肿瘤抑制作用。需要进一步研究以揭示miR-191-5p的潜在信号通路及其作为早期检测和预后预测生物标志物以及RCC治疗靶点的潜在作用。